Candel Therapeutics (CADL) 2025 Conference September 04, 2025 08:00 AM ET Speaker0Everyone. Welcome to the second day of Cantor's Global Healthcare Conference. I am delighted to be joined today by Paul Peter Tak, the CEO of Candel Therapeutics. Welcome. So Paul Peter, kick us off by a quick overview of Candel.Speaker1Yes. Well, thanks for having us. It's great to be here. Hi all. Candel Therapeutics develops viral immunotherapies for very difficult to treat solid tumors.And we've shown consistently positive ...

Candel Therapeutics (CADL) Conference September 03, 2025 09:00 AM ET Company ParticipantsPaul Peter Tak - President, CEO & DirectorYigal Nochomovitz - DirectorCharles Schoch - CFOPaul Peter TakGood morning.Yigal NochomovitzOkay.Okay. All right, we can go. All right, is it working? I see a red color here. It's on? Okay.Paul Peter TakIt's on here as well.Yigal NochomovitzYeah, good. Great.Paul Peter TakIt's good.Yigal NochomovitzAll right. Welcome everyone to day two of Citi's Back to School Summit. We're all ...

Candel Therapeutics (CADL) 2025 Conference June 05, 2025 11:40 AM ET Speaker0 Morning, everybody. Welcome to the Jefferies Global Healthcare Conference. My name is Brett Gallagher with the Healthcare Investment Banking team. It's now my pleasure to invite Paul Peter Tock from Candel Therapeutics up to the stage. Speaker1 Thank you very much. A very good morning, everybody. It's great to be here and to present our programs at Candel Therapeutics. We are focused on the development of viral immunotherapies for ...